CompletedNCT03653858

Efficacy Study of Deep Brain Stimulation in Patients With Treatment Resistant Major Depression

Device studyAges 20–75France + Germany

The study in practice

Understand this study

This study was for people with depression. Listed age limits: 20 years to 75 years. Other eligibility criteria applied.

Listed locations: Grenoble and 1 more locationSee all locations and recruitment

Study clarity

Study start dateStarted: September 3, 2018

Recruitment status: Completed
Enrollment listed in the registry: 46
Sponsor: University Hospital Freiburg
Sponsor type: Hospital / academic medical center
Study type: Device
Intervention type: DEVICE
Study phase: Not clearly listed
Locations: France, Germany
Age range: From 20 Years to 75 Years
Official registry ID: NCT03653858
Official title: Show the full official title
Controlled Randomized Clinical Trial to Assess Efficacy of Deep Brain Stimulation (DBS) of the slMFB in Patients With Treatment Resistant Major Depression

Completed

Grenoble, France · Freiburg im Breisgau, Germany

FAQ

Who is behind this study?

The study sponsor is University Hospital Freiburg, a hospital or academic medical center.

Who was this study for?

This study was for people with depression. Listed age limits: 20 years to 75 years. Other eligibility criteria applied.

Explore other studies

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.